We treated the PAH SD rats with TMS and found that NF-κB, IL-6, and TNF-α were inhibited in myocardial tissue and peripheral blood, which provides a potential new strategy and direction in exploring the possible mechanism of the development of PAH and the underlying mechanisms of TMS and other similar candidate treatments. Here, NFKB1 is linked to pulmonary arterial hypertension.